据近期出版的《新英格兰医学杂志》(NEJM)报道,与已确定的检验方法相比,一种新的血液癌细胞计数技术有助于更快捷和更准确地预测乳腺癌的治疗是否成功;新的技术可使医生在几周之内而不是数月即可确定对乳腺癌病人的治疗是否奏效。美国得克萨斯大学 Anderson癌症研究中心的 Massimo Cristo-fanilli 博士对此指出,由协助研发该项新技术的公司资助的研究可产生更多种适宜的治疗以使一 According to the recently published NEJM, a new hematological cancer cell count technique can be used to predict more quickly and accurately the success of breast cancer treatment than the established test methods; The new technology allows physicians to determine whether treatment for breast cancer patients will work within weeks instead of months. Massimo Cristo-fanilli, PhD, of the Anderson Cancer Center at the University of Texas, in the United States, points out that research funded by companies that assist in the development of the new technology can produce more appropriate treatments to make a